Possess advanced science and technology, many of which are very mature and can accept challenges.
Alfa Oncology provides global partners with a full range of tumor microenvironment related research services and integrated end-to-end solutions, covering all angles of tumor microenvironment research. So that anyone and any company can achieve the purpose of helping research success through our integrated and open TME central technology platform. We are committed to accelerating the in-depth understanding of the tumor microenvironment through the TME central technology platform, helping global customers to bring more innovative therapies to the market as soon as possible to benefit patients.
The TME Center technology platform consists of a series of separate business platforms, including microfluidics technology platform, sequencing technology platform, mass spectrometry technology platform, imaging technology platform, immune cell technology platform, stem cell technology platform, animal model technology platform, and animal experiment platform etc. The TME center technology platform can freely combine platform technologies according to different research purposes to support various single or integrated projects.